原文链接: Chan Xie , Dongying Xie , Qihuan Xu , et al. The Everest Project’s 5-Year Update: Efficacy of PegIFNα Therapy in NA-suppressed HBeAg negative CHB. APASL 2024 Abstract O-0161 来源:《国际肝病》编辑部 声...
Chan Xie , Dongying Xie , Qihuan Xu , et al. The Everest Project’s 5-Year Update: Efficacy of PegIFNα Therapy in NA-suppressed HBeAg negative CHB. APASL 2024 Abstract O-0161
Chan Xie , Dongying Xie , Qihuan Xu , et al. The Everest Project’s 5-Year Update: Efficacy of PegIFNα Therapy in NA-suppressed HBeAg negative CHB. APASL 2024 Abstract O-0161